XTL Biopharmaceuticals Ltd. (XTLB)

NASDAQ: XTLB · Real-Time Price · USD

Compare

0.8610

-0.0390 (-4.33%)

At close: Nov 19, 2025, 4:00 PM EST

0.8775

+0.0165 (1.92%)

Pre-market: Nov 20, 2025, 4:21 AM EST

XTL Biopharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	0.45	-	-	-	-	Upgrade
Cost of Revenue	0.45	-	-	-	-	Upgrade
Gross Profit	0	-	-	-	-	Upgrade
Selling, General & Admin	2.08	0.73	0.85	1	0.91	Upgrade
Research & Development	0.1	0.03	0.03	0.03	0.04	Upgrade
Operating Expenses	2.18	0.77	0.88	1.03	0.95	Upgrade
Operating Income	-2.17	-0.77	-0.88	-1.03	-0.95	Upgrade
Interest Expense	-0.03	-	-	-	-	Upgrade
Interest & Investment Income	0.03	0.04	0.04	0.01	0.03	Upgrade
Currency Exchange Gain (Loss)	-0.03	-0.03	-0.02	0.01	0.01	Upgrade
Other Non Operating Income (Expenses)	-0.06	-0	-0.01	0.7	-2.19	Upgrade
EBT Excluding Unusual Items	-2.25	-0.76	-0.87	-0.31	-3.09	Upgrade
Gain (Loss) on Sale of Investments	1.09	-1.02	-0.48	0.75	0.14	Upgrade
Pretax Income	-1.16	-1.78	-1.35	0.44	-2.95	Upgrade
Income Tax Expense	-0.13	-	-	-	-	Upgrade
Earnings From Continuing Operations	-1.03	-1.78	-1.35	0.44	-2.95	Upgrade
Net Income	-1.03	-1.78	-1.35	0.44	-2.95	Upgrade
Net Income to Common	-1.03	-1.78	-1.35	0.44	-2.95	Upgrade
Shares Outstanding (Basic)	673	545	545	532	514	Upgrade
Shares Outstanding (Diluted)	704	545	545	616	514	Upgrade
Shares Change (YoY)	29.23%	-0.00%	-11.48%	19.71%	-	Upgrade
EPS (Basic)	-0.00	-0.00	-0.00	0.00	-0.01	Upgrade
EPS (Diluted)	-0.00	-0.00	-0.00	0.00	-0.01	Upgrade
Free Cash Flow	-1.67	-0.71	-0.9	-1.05	-0.85	Upgrade
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	Upgrade
Gross Margin	0.66%	-	-	-	-	Upgrade
Operating Margin	-481.60%	-	-	-	-	Upgrade
Profit Margin	-227.72%	-	-	-	-	Upgrade
Free Cash Flow Margin	-370.73%	-	-	-	-	Upgrade
EBITDA	-1.97	-0.76	-0.88	-1.03	-0.95	Upgrade
D&A For EBITDA	0.2	0	0	0	0	Upgrade
EBIT	-2.17	-0.77	-0.88	-1.03	-0.95	Upgrade
Advertising Expenses	0.16	-	-	-	-	Upgrade

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q